Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 4 |
Netflix
NFLX
|
+$598M |
| 5 |
Amazon
AMZN
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.46B |
| 2 |
SNDK
Sandisk
SNDK
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$426M |
| 4 |
Linde
LIN
|
+$316M |
| 5 |
Vertiv
VRT
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Healthcare | 14.83% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIP
2901
Vulcan Infrastructure and Power
VIP
$36.3M
| $180K | ﹤0.01% |
100,300
+12,000
| +14% | +$16.3K |
|
2902
Independence Realty Trust
IRT
$3.75B
| $179K | ﹤0.01% |
+10,695
| New | +$173K |
|
|
AHT
2903
Ashford Hospitality Trust
AHT
$20.5M
| $178K | ﹤0.01% |
54,803
-1,500
| -3% | -$4.47K |
|
2904
NanoViricides
NNVC
$27.6M
| $177K | ﹤0.01% |
128,600
-6,300
| -5% | -$8.64K |
|
2905
Lipocine
LPCN
$19.5M
| $177K | ﹤0.01% |
69,209
+30,712
| +80% | +$73.9K |
|
|
BBNX
2906
Beta Bionics
BBNX
$870M
| $177K | ﹤0.01% |
+11,300
| New | +$134K |
|
2907
Avalon Holdings
AWX
$10.5M
| $176K | ﹤0.01% |
70,810
-5,172
| -7% | -$13.1K |
|
2908
Summit State Bank
SSBI
$86.2M
| $175K | ﹤0.01% |
12,890
+300
| +2% | +$4.08K |
|
2909
Simply Good Foods
SMPL
$952M
| $174K | ﹤0.01% |
13,100
-109,900
| -89% | -$1.36M |
|
|
TVRD
2910
Tvardi Therapeutics
TVRD
$25.9M
| $174K | ﹤0.01% |
91,409
-691
| -0.8% | -$2.17K |
|
2911
Guardforce AI
GFAI
$11.7M
| $172K | ﹤0.01% |
432,100
+36,900
| +9% | +$17.8K |
|
2912
electroCore
ECOR
$81.9M
| $172K | ﹤0.01% |
19,900
-24,509
| -55% | -$183K |
|
2913
Boston Omaha
BOC
$413M
| $169K | ﹤0.01% |
+12,400
| New | +$156K |
|
2914
Core Laboratories
CLB
$572M
| $169K | ﹤0.01% |
14,500
-36,103
| -71% | -$515K |
|
|
HKD
2915
AMTD Digital
HKD
$547M
| $169K | ﹤0.01% |
106,158
+14,358
| +16% | +$24.4K |
|
|
TOYO
2916
TOYO Co
TOYO
$192M
| $168K | ﹤0.01% |
24,200
-21,800
| -47% | -$268K |
|
2917
Playboy Inc
PLBY
$141M
| $168K | ﹤0.01% |
137,800
-287,559
| -68% | -$436K |
|
2918
Anixa Biosciences
ANIX
$98.7M
| $166K | ﹤0.01% |
59,373
-1,800
| -3% | -$5.01K |
|
2919
VistaGen Therapeutics
VTGN
$10.8M
| $165K | ﹤0.01% |
730,500
+439,200
| +151% | +$265K |
|
2920
P3 Health Partners
PIII
$35.1M
| $164K | ﹤0.01% |
+15,149
| New | +$113K |
|
|
BLNE
2921
Beeline Holdings
BLNE
$33.6M
| $159K | ﹤0.01% |
130,695
+113,739
| +671% | +$187K |
|
2922
Willamette Valley Vineyards
WVVI
$10.9M
| $159K | ﹤0.01% |
63,352
-2,700
| -4% | -$7.29K |
|
2923
Destination XL Group
DXLG
$34.8M
| $159K | ﹤0.01% |
237,272
-51,500
| -18% | -$33.9K |
|
2924
NRX Pharmaceuticals
NRXP
$150M
| $158K | ﹤0.01% |
+38,600
| New | +$128K |
|
2925
Mannatech
MTEX
$17.3M
| $157K | ﹤0.01% |
30,078
-800
| -3% | -$4.15K |
|
Similar funds
Renaissance Technologies's Q2 2026 Portfolio in Review
As of Q2 2026, Renaissance Technologies held 3,761 positions worth $72.6B, up 14% from $63.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2026 filing shows 548 new, 1,084 increased, 1,502 reduced and 621 closed positions. Its largest new stake was Amazon: 2,290,710 shares worth $546M. The largest sale was Micron Technology, an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2026 buy was Amazon: 2,290,710 shares worth $546M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q2 2026, an estimated $1.08B increase.
- Renaissance Technologies's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.46B.
- Renaissance Technologies fully exited Applovin in Q2 2026, selling an estimated $174M.
- Renaissance Technologies's ten largest holdings make up 12% of its $72.6B portfolio in Q2 2026.
- Renaissance Technologies opened 548 new positions and closed 621 in Q2 2026.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $72.6B.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.